Canine Cancer: Strategies in Experimental Therapeutics

por Thamm, Douglas H.
Publicado 2019

Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs

por Brady, Rachel V., Thamm, Douglas H.
Publicado 2023

The effect of Zhangfei/CREBZF on cell growth, differentiation, apoptosis, migration, and the unfolded protein response in several canine osteosarcoma cell lines

por Zhang, Rui, Thamm, Douglas H, Misra, Vikram
Publicado 2015

Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy

por Faulhaber, Erica A., Janik, Emily, Thamm, Douglas H.
Publicado 2021

Systems biology approach to identification of biomarkers for metastatic progression in cancer

por Ptitsyn, Andrey A, Weil, Michael M, Thamm, Douglas H
Publicado 2008

The immunosignature of canine lymphoma: characterization and diagnostic application

por Johnston, Stephen Albert, Thamm, Douglas H, Legutki, Joseph Barten
Publicado 2014

3114 Investigating the therapeutic potential of parthenolide in the treatment of hematopoietic neoplasms in dogs

por Schlein, Lisa J, Peterson, Aubree, Rose, Barbara, Thamm, Douglas
Publicado 2019

Hematopoietic Tumors

por Vail, David M., Thamm, Douglas H., Liptak, Julias M.
Publicado 2019

Retrospective Evaluation of Outcome in Dogs With Appendicular Osteosarcoma Following Hypofractionated Palliative Radiation Therapy With or Without Bisphosphonates: 165 Cases (2010–...

por Ringdahl-Mayland, Beck, Thamm, Douglas H., Martin, Tiffany W.
Publicado 2022

Bisphosphonate conjugation for bone specific drug targeting

por Farrell, Kristen B., Karpeisky, Alexander, Thamm, Douglas H., Zinnen, Shawn
Publicado 2018

In vitro antineoplastic effects of auranofin in canine lymphoma cells

por Zhang, Hong, Rose, Barbara J., Pyuen, Alex A., Thamm, Douglas H.
Publicado 2018

In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma

por Pyuen, Alex A., Meuten, Travis, Rose, Barbara J., Thamm, Douglas H.
Publicado 2018

Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy

por Heishima, Kazuki, Meuten, Travis, Yoshida, Kyoko, Mori, Takashi, Thamm, Douglas H.
Publicado 2019

Prognostic value of fluorine(18) flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma

por Griffin, Lynn R., Thamm, Douglas H., Brody, Ariel, Selmic, Laura E.
Publicado 2019

Partial ulnar ostectomy, stereotactic body radiation therapy, and palliative radiation therapy as local limb sparing treatment modalities for ulnar tumors in dogs

por Griffin, Maureen A., Martin, Tiffany Wormhoudt, Thamm, Douglas H., Worley, Deanna R.
Publicado 2023

Evaluation of prognostic markers for canine mast cell tumors treated with vinblastine and prednisone

por Webster, Joshua D, Yuzbasiyan-Gurkan, Vilma, Thamm, Douglas H, Hamilton, Elizabeth, Kiupel, Matti
Publicado 2008

Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma

por Siewert, Jacob M., Gustafson, Daniel L., Weishaar, Kristen M., Galloway, Annie M., Thamm, Douglas H.
Publicado 2023

DNA Repair Deficiency as a Susceptibility Marker for Spontaneous Lymphoma in Golden Retriever Dogs: A Case-Control Study

por Thamm, Douglas H., Grunerud, Kristen K., Rose, Barbara J., Vail, David M., Bailey, Susan M.
Publicado 2013

Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma

por Thamm, Douglas H., Joseph, Jenette K., Rose, Barbara J., Meuten, Travis K., Weishaar, Kristen M.
Publicado 2020

Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines

por Maeda, Junko, Froning, Coral E., Brents, Colleen A., Rose, Barbara J., Thamm, Douglas H., Kato, Takamitsu A.
Publicado 2016